The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL) validated in adult T-ALL patients the clinical utility of a new oncogenetic classifier based on the mutational status of NOTCH1/FBXW7/PTEN/RAS (NFPR) genes (28). This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.